Cardiovascular dysautonomia as a cause of falls in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 12, Issue 4, 2006, Pages 195-204

  Martignoni, Emilia ^a   Tassorelli, Cristina ^b   Nappi, Giuseppe ^b  

^a IRCCS   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Cardiovascular dysautonomia; falls; Orthostatic hypotension; Parkinson's disease; Postprandial hypotension

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CABERGOLINE; CAFFEINE; DESMOPRESSIN; DIHYDROERGOTAMINE; DOMPERIDONE; ENTACAPONE; EPHEDRINE; ERYTHROPOIETIN; FLUDROCORTISONE; FLURBIPROFEN; INDOMETACIN; LEVODOPA; LISURIDE; MIDODRINE; NORADRENALIN; OCTREOTIDE; PHENYLEPHRINE; PINDOLOL; PRAMIPEXOLE; PROPRANOLOL DERIVATIVE; ROPINIROLE; SELEGILINE; THREO 3,4 DIHYDROXYPHENYLSERINE; TYRAMINE; UNINDEXED DRUG; XAMOTEROL; YOHIMBINE;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANOREXIA; ANXIETY; BODY EQUILIBRIUM; BRACE; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CAROTID SINUS SYNDROME; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIET; DIGESTIVE SYSTEM ULCER; DISEASE EXACERBATION; DIZZINESS; DYSAUTONOMIA; DYSPNEA; EDEMA; EPIGASTRIC PAIN; EXCITABILITY; EXERCISE; FALL RISK; FATIGUE; FLU LIKE SYNDROME; FLUSHING; GALACTORRHEA; GALLBLADDER DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL IRRITATION; GLUCOSURIA; GYNECOMASTIA; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; HYPOTHYROIDISM; INSOMNIA; IRRITABILITY; MENTAL DISEASE; MYALGIA; NAUSEA; NERVOUSNESS; NITROGEN BALANCE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PARKINSON DISEASE; POSTPRANDIAL STATE; POTASSIUM DEFICIENCY; PRIORITY JOURNAL; RESTLESSNESS; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SINUS BRADYCARDIA; SKIN IRRITATION; SODIUM DEFICIENCY; STOMACH DISEASE; SYNCOPE; TACHYCARDIA; THORAX PAIN; TREMOR; VERTIGO; AUTONOMIC NEUROPATHY; FALLING; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; STATISTICS;

ACCIDENTAL FALLS; AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; HUMANS; MUSCULOSKELETAL EQUILIBRIUM; PARKINSON DISEASE; RISK;

EID: 33746926771     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.02.001     Document Type: Review

References (104)

1. American Geriatric Society, British geriatric society, and American academy of orthopaedic surgeons panel on falls prevention. Guideline for the prevention of falls in older persons. J Am Geriatr Soc; 2001;49:664-72.
2. Bloem B.R., Steijns J.A.G., and Smits-Engelsman B.C. An update on falls. Curr Opin Neurol 16 (2003) 15-26
3. Blake A.J., Morgan K., Bendall M.J., Dallosso H., Ebrahim S.B., Arie T.H., Fentem P.H., and Bassey E.J. Falls by elderly people at home: prevalence and associated factors. Age Ageing 17 (1988) 365-372
4. Alexander B.H., Rivara F.P., and Wolf M.E. The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health 82 (1992) 1020-1023
5. Ashburn A., Stack E., Pickering R.M., and Ward C.D. A community-dwelling sample of people with Parkinson's disease:characteristics of fallers and non-fallers. Age Ageing 30 (2001) 47-52
6. Gray P., and Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs 32 (2000) 222-228
7. Bloem B.R., Grimbergen Y.A.M., Cramer M., Willemsen M., and Zwinderman A.H. Prospective assessment of falls in Parkinson's disease. J Neurol 248 (2001) 950-958
8. Wood B.H., Bilclough J.A., Bowron A., and Walker R.W. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 72 (2002) 721-725
9. Martignoni E, Godi L, Citterio A, Zangaglia R, Riboldazzi G, Calandrella D, Pacchetti C, Nappi G. The Parkinson's Disease Comorbidity Study Group Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study. Neurol Sci 2004;25:66-71.
10. de Carle A.J., and Kohn R. Risk factors for falling in apsychiatric geriatric unit. Int J Geriatr Psychiatry 16 (2001) 762-767
11. Martignoni E., Pacchetti C., Micieli G., and Nappi G. Autonomic disturbances in Parkinson's disease and Shy-Drager syndrome. In: Korczyn A.D. (Ed). Handbook of autonomic nervous system dysfunction (1995), Marcel Dekker, New York 235-252
12. Allcock L.M., Ullyart K., Kenny R.A., and Burn D.J. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 75 (2004) 1470-1471
13. Catz A., and Korczyn A. Aging and the autonomic nervous system. In: Appenzeller O. (Ed). Handbook of clinical neurology vol 74(30): the autonomic nervous system part I normal functions (1999), Elsevier Science B.V., Amsterdam 225-243
14. van Dijk J.G., Haan J., Zwinderman K., Kremer B., van Hilten J.J., and Roos R.A. Autonomic nervous system dysfunction in Parkinson's disease: relationship with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry 56 (1993) 1090-1095
15. Fearnley J., and Lees A. Pathology of Parkinson's disease. In: Calne D.B. (Ed). Neurodegenerative diseases (1994), W.B. Saunders Company, Philadelphia 545-554
16. Balaban C.D., and Beryozkin G. Vestibular nucleus projections to nucleus tractus solitarius and the dorsal motor nucleus of the vagus nerve: potential substrates for vestibulo-autonomic interactions. Exp Brain Res 98 (1994) 200-212
17. Ruggiero D.A., Mtui E.P., Otake K., and Anwar M. Vestibular afferents to the dorsal vagal complex: substrate for vestibular-autonomic interaction in the rat. Brain Res 743 (1996) 294-302
18. Mittelstaedt H. Interaction of eye-, head-, and trunk-bound information in spatial perception and control. J Vestib Res 7 (1997) 283-302
19. Kerman I.A., and Yates B.J. Regional and functional differences in the distribution of vestibulosympathetic reflexes. Am J Physiol 275 (1998) R824-R835
20. Kerman I.A., McAllen R.M., and Yates B.J. Patterning of sympathetic nerve activity in response to vestibular stimulation. Brain Res Bull 53 (2000) 11-16
21. Balaban C.D., and Porter J.D. Neuroanatomic substrates for vestibulo-autonomic interactions. J Vestib Res 8 (1998) 7-16
22. Yates B.J., Holmes M.J., and Jian B.J. Adaptive plasticity in vestibular influences on cardiovascular control. Brain Res Bull 53 (2000) 3-9
23. Yates B.J. Autonomic reaction to vestibular damage. Otolaryngol Head Neck Surg 119 (1998) 106-112
24. Vaitl D., Mittelstaedt H., Saborowski R., Stark R., and Baisch F. Shifts in blood volume alter the perception of posture: further evidence for somatic graviperception. Int J Psychophysiol 44 (2002) 1-11
25. Radtke A., Popov K., Bronstein A.M., and Gresty M.A. Vestibulo-autonomic control in man: short- and long-latency vestibular effects on cardiovascular function. J Vestib Res 13 (2003) 25-37
26. Farkas E., Jansen A.S., and Loewy A.D. Periacqueductal gray matter iput to cardiac-related sympathetic premotor neurons. Brain Res 792 (1998) 179-192
27. Ciriello J., McMurray J.C., Babic T., and de Oliveira C.V. Collateral axonal projections from hypothalamic hyposecretin neurons to cardiovascular sites in nucleus ambiguus and nucleus tractus solitarius. Brain Res 991 (2003) 133-141
28. Takeuchi Y., Xie Q., Miki T., Matsumoto Y., Satriotomo I., Li H.P., and Gu H. Parabrachial inputs to Fos-immunoreactiveneurons in the lateral central nucleus of amygdala activated by hypotension: light and electron microscopic study in the rat. Brain Res Bull 64 (2004) 171-180
29. Aminoff M.J., and Wilcox C.S. Assessment of autonomic function in patients with a parkinsonian syndrome. Br Med (1971)
30. Appenzeller O., and Goss J.E. Autonomic deficits in Parkinson's syndrome. Arch Neurol 24 (1971) 50-57
31. Bonuccelli U., Lucetti C., Del Dotto P., Ceravolo R., Gambaccini G., Bernardini S., Rossi G., and Piaggesi A. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol 60 (2003) 1400-1404
32. Pursiainen V., Haapaniemi T.H., Korpelainen J.T., Huikuri H.V., Sotaniemi K.A., and Myllyla V.V. Circadian heart rate variability in Parkinson's disease. J Neurol 249 (2002) 1535-1540
33. Kallio M., Suominen K., Haapaniemi T., Sotaniemi K., Myllyla V.V., Astafiev S., and Tolonen U. Nocturnal cardiac autonomic regulation in Parkinson's disease. Clin Auton Res 14 (2004) 119-124
34. Devos D., Kroumova M., Bordet R., Vodougnon H., Guieu J.D., Libersa C., and Destee A. Heart rate variability and Parkinson's disease severity. J Neural Transm 110 (2003) 997-1011
35. Akincioglu C., Unlu M., and Tunc T. Cardiac innervation and clinical correlates in idiophatic Parkinson's disease. Nucl Med Commun 24 (2003) 267-271
36. Li S.T., Dendi R., Holmes C., and Goldstein D.S. Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann Neurol 52 (2002) 220-223
37. Singleton A., Gwinn-Hardy K., Sharabi Y., Li S.T., Holmes C., Dendi R., Hardy J., Singleton A., Crawley A., and Goldstein D.S. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127 (2004) 768-772
38. Goldstein D.S. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2 (2003) 669-676
39. Gurevich T.Y., Groozman G.B., Giladi N., Drory V.E., Hausdorff J.M., and Korczyn A.D. R-R interval variation in Parkinson's disease and multiple system atrophy. Acta Neurol Scand 109 (2004) 276-279
40. Courbon F., Brefel-Courbon C., Thalamas C., Alibelli M.J., Berry I., Montastruc J.L., Rascol O., and Senard J.M. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 18 (2003) 890-897
41. Nagayama H., Hamamoto M., Ueda M., Nagashima J., and Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 76 (2005) 249-251
42. Martignoni E., Micieli G., Cavallini A., Pacchetti C., Magri M., and Nappi G. Autonomic disorders in idiopathic parkinsonism. J Neural Transm 22 (1986) 149-161
43. Nappi G., Micieli G., Martignoni E., Sandrini G., Pacchetti C., and Horowski R. Circadian and ultradian rhythms of core temperature in Parkinson's disease. J Autonom Nerv Syst Suppl (1986) 571-574
44. Micieli G., Tassorelli C., Martignoni E., Pacchetti C., Bruggi P., Magri M., and Nappi G. Disordered pupil reactivity in Parkinson's disease. Clin Auton Res 1 (1991) 55-58
45. Carey B.J., and Potter J.F. Cardiovascular causes of falls. Age Ageing 30-S4 (2001) 19-24
46. Grubb B.P., and Samoil D. Neurocardiogenic syncope. In: Kenny R.A. (Ed). Syncope in the older patient (1996), Chapman&Hall, London 91-106
47. Potulska A., Friedman A., Królicki, and Spychala A. Swallowing disorders in Parkinson's disease. Parkinsonism Relat Disord 9 (2003) 349-353
48. Dey A.B., Stout N.R., and Kenny R.A. Cardiovascular syncope is the most common cause of drop attacks in the elderly. Pacing Clin Electrophysiol 20 (1997) 818-819
49. Richardson D.A., Bexton R.S., Shaw F.E., and Kenny R.A. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to an accident and emergency department with unexplained or recurrent falls. Pacing Clin Electrophysiol 20 (1997) 820-823
50. Raschetti R., Spilla-Alegiani S., Vanacore N., Ancona C., and Meco G. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs. Acta Neurol Scand 97 (1998) 20-26
51. Leoni O., Martignoni E., Cosentino M., Michielotto D., Calandrella D., Zangaglia R., Riboldazzi G., Oria C., Lecchini S., Nappi G., and Frigo G. Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf 11 (2002) 149-157
52. Brignole M., Menozzi C., Lolli G., Bottoni N., and Gaggioli G. Long term outcome of paced and non-paced patients with severe carotid sinus syndrome. Am J Cardiol 69 (1992) 1039-1043
53. Senard J.M., Rai S., Lapeyre-Mestre M., Brefel C., Rascol O., Rascol A., and Montastruc J.L. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 63 (1997) 584-589
54. Viramo P., Luukinen H., Koski K., Laippala P., Sulkava R., and Kivela S.L. Orthostatic hypotension and cognitive decline in older people. J Am Geriatr Soc 47 (1999) 600-604
55. Magerkurth C., Schnitzer R., and Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 15 (2005) 76-82
56. Micieli G., Martignoni E., Cavallini A., Sandrini G., and Nappi G. Postprandial and orthostatic hypotension in Parkinson's disease. Neurology 37 (1987) 386-393
57. Niehaus L., Bockeler G.C., Kupsch A., and Meyer B.U. Normal cerebral hemodynamic response to ortostasis in Parkinson's disease. Parkinsonism Relat Disord 8 (2002) 255-259
58. Vloet L.C., Pel-Little R.F., Jansen P.A., and Jansen R.W. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to dutch hospitals. J Gerontol Biol Sci Med Sci 60 (2005) 1271-1277
59. Fischer A.A., Davis M.W., Srikusalanukul W., and Budge M.M. Postprandial hypotension predicts all-cause mortality in older, low level care residents. J Am Geriatr Soc 53 (2005) 1313-1320
60. Jansen R.W., and Lipsitz L.A. Postprandial hypotension, epidemiology, pathophysiology and clinical management. Ann Intern Med 122 (1995) 286-295
61. Mehagnoul-Schipper D.J., Boerman R.H., Hoefnagels W.H., and Jansen R.W. Effect of levodopa on othostatic and postprandial hypotension in elderly parkinsonian patients. J Gerontol A Biol Sci Med Sci 56 (2001) M749-M755
62. Chauduri K.R., Ellis C., Love-Jones S., Thomaides T., Clift S., Mathias C.J., and Parkes J.D. Postprandial hypotension and parkinsonian state in Parkinson's disease. Mov Disord 12 (1997) 877-884
63. Smith N.L., Psaty B.M., Rutan G.H., Lumley T., Yanez D., Chaves P.H., and Kronmal R.A. The association between time since last meal and blood pressure in older adults: the cardiovascular health study. J Am Geriatr Soc 51 (2003) 824-828
64. Le Couteur D.G., Fisher A.A., Davis M.W., and McLean A.J. Postprandial systolic blood pressure responses of older people in residential care: association with risk of falling. Gerontology 49 (2003) 260-264
65. Vloet L.C., Smits R., and Jansen R.W. The effect of meals at different mealtimes on blood pressure and symptoms in geriatric patients with postprandial hypotension. J Gerontol A Biol Sci Med Sci 58 (2003) 1031-1035
66. Potter J.F., Heseltine D., Hartley G., Matthews J., Mac Donald I.A., and James O.F. Effects of meal composition on the postprandial blood pressure, catecholamine and insulin changes in elderly subjects. Clin Sci 77 (1989) 265-272
67. Berry M.K., Russo A., Wishart J.M., Tonkin A., Horowitz M., and Jones K.L. Effect of solid meal on gastric emptying of, and glycemic and cardiovascular response to, liquid glucose in older subjects. Am J Physiol Gastrointest Liver Physiol 284 (2003) G655-G662
68. Masuda Y., and Kawamura A. Role of autonomic nervous system in postprandial hypotension in elderly persons. J Cardiovasc Pharmacol 42 Suppl. 1 (2003) S23-S26
69. Calne D.B., Brennan J., Spiers A.S.D., and Stern G.M. Hypotension caused by l-dopa. Br Med J 1 (1970) 474-475
70. Gross M., Bannister R., and Godwin-Austen R. Othostatic hypotension in Parkinson's disease. Lancet 1 (1972) 174-176 72
71. Sachs C., Bergend B., and Kaijser L. Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition. Acta Neurol Scand 71 (1985) 37-42
72. Senard J.M., Verwaerde P., Rascol O., and Montastruc J.L. Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians. Hypertens Res 18 S1 (1995) S175-S177
73. Quadri R., Comino I., Scarzella L., Cacioli P., Zanone M.M., Pipieri A., Bergamasco B., and Chiandussi L. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration. Funct Neurol 15 (2000) 81-86
74. Bouhaddi M., Vuillier F., Fortrat J.O., Cappelle S., Henriet M.T., Rumbach L., and Regnard J. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of l-dopa therapy. Auton Neurosci 116 (2004) 30-38
75. Kujawa K., Leurgans S., Raman R., Blasucci L., and Goetz C.G. Acute orthostatic hypotension when starting dopamine agonist in Parkinson's disease. Arch Neurol 57 (2000) 1461-1463
76. Amenta F., Ricci A., Tayebati S.K., and Zaccheo D. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 107 (2002) 145-167
77. Quinn N.P., Illas A., Lhermitte F., and Agid Y. Bromocriptine in Parkinson's disease: a study of cardiovascular side effects. J Neurol Neurosur Psychiatry 44 (1981) 426-429
78. Micieli G., Martignoni E., Cavallini A., Pacchetti C., Rossi F., Horowski R., and Nappi G. Lisuride and bromocriptine in l-dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects. Funct Neurol 11 (1996) 317-325
79. Bracco F., Battaglia A., Chouza C., Dupont E., Gershanik O., Marti Masso J.F., Montastruc J.L., and PKDS009 Study group. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease final results of a 5-year, double blind, levodopa-controlled study. CNS Drugs 18 (2004) 733-746
80. Inzelberg R., Schechtman E., and Nisipeanu P. Cabergoline, pramipexole and ropinirole used as monotheraphy in early Parkinson's disease: an evidence-based comparison. Drug Aging 20 (2003) 847-855
81. Churchyard A., Mathias C.J., and Lees A.J. Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal. Mov Disord 14 (1999) 246-251
82. Bhattacharya K.F., Nouri S., Olanow C.W., Yahr M.D., and Kaufmann H. Selegiline in the treatment of Parkinson's disease:its impact on orthostatic hypotension. Parkinsonism Relat Disord 9 (2003) 221-224
83. Korchounov A., Kessler K.R., and Schipper H.I. Differential effects of various treatment combinations on the cardiovascular dysfunction in patients with Parkinson's disease. Acta Neurol Scand 109 (2004) 45-51
84. Henhliffe C., and Waters C. Entacapone in the management of Parkinson's disease. Expert Opin Pharmacother 3 (2002) 957-963
85. Lyytinen J., Sovijarvi A., Kaakkola S., Gordin A., and Teravainen H. The effect of catechol-O-methyltranferse inhibition with entacapone on cardiovascular autonomic responses in l-Dopa treated patients with Parkinson's disease. Clin Neuropharmacol 24 (2001) 50-57
86. Haapaniemi T.H., Kallio M.A., Korpelainen J.T., Suominen K., Tolonen U., Sotaniemi K.A., and Myllyla V.V. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease. J Neurol 247 (2000) 868-874
87. Rajendran P.R., Thompson R.E., and Reich S.G. The use of alternative therapies by patients with Parkinson's disease. Neurology 57 (2001) 790-794
88. Bailey D.G., and Dresser G.K. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 4 (2004) 281-297
89. Goetz C.G., Koller W.C., Poewe W., Rascol O., Sampaio C., Brin M.F., Lees A.J., LeWitt P., Lozano A., Mizuno Y., Nutt J., Oertel W., Olanow C.W., and Tolosa E. Management of Parkinson's disease: an evidence-based review. Mov Disord 17S4 (2002) S103-S111
90. Kaufmann H., Saadia D., Voustianiouk A., Goldstein D.S., Holmes C., Yahr M.D., Nardin R., and Freeman R. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108 (2003) 724-728
91. Freeman R. Treatment of orthostatic hypotension. Semin Neurol 23 (2003) 435-442
92. Shannon J.R., Diedrich A., Biaggioni I., Tank J., Robertson R.M., Robertson D., and Jordan J. Water drinking as a treatment for orthostatic syndromes. Am J Med 112 (2002) 355-360
93. Tachtsidis I., Elwell C.E., Leung T.S., Lee C.W., Smith M., and Delpy D.T. Investigation of cerebral haemodynamics by near-infrared spectroscopy in young healthy volunteers reveals posture-dependent spontaneous oscillations. Physiol Meas 25 (2004) 437-445
94. Harrap S.B., Cui J.S., Wong Z.Y., and Hopper J.L. Familial and genomic analyses of postural changes in systolic and diastolic blood pressure. Hypertension 43 (2004) 586-591
95. El-Sayed H., and Hainsworth R. Relationship between plasma volume, carotid baroreceptor sensitivity and othostatic tolerance. Clin Sci 88 (1995) 463-470
96. Claydon V.E., Norcliffe L.J., Moore J.P., Rivera C.H.M., Leon-Velarde F., Appenzeller O., and Hainsworth R. Othostatic tolerance and blood volumes in Andean high altitude dwellers. Exp Physiol 89 (2004) 565-571
97. Moore A., Ryan J., Wats M., Pillay I., Clinch D., and Lyons D. Orthostatic tolerance in older patients with vitamin B12 deficiency before and after vitamin B12 replacement. Clin Auton Res 14 (2004) 67-71
98. Toru S., Yokota T., Inaba A., Yamawaki M., Yamada M., Mizusawa H., and Hayashi M. Autonomic dysfunction and orthostatic hypotension caused by vitamin B12 defieciency. J Neurol Neurosurg Psychiatry 66 (1999) 804-805
99. Sarasin F.P., Louis-Simonet M., Cardballo D., Slama S., Junod A.F., and Unger P.F. Prevalence of orthostatic hypotension among patients presenting with syncope in the ED. Am J Emerg Med 20 (2002) 497-501
100. Li F., Fisher K.J., Harmer P., McAuley E., and Wilson N.L. Fear of falling in elderly persons: association with falls, functional ability, and quality of life. J Gerontol Psychol Sci 58B (2003) P283-P290
101. Adkin A.L., Frank J.S., and Jog M.S. Fear of falling and postural control in Parkinson's disease. Mov Disord 18 (2003) 496-502
102. Gillespie L.D., Gillespie W.J., Robertson M.C., Lamb S.E., Cumming R.G., and Rowe B.H. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 4 (2003) CD000340
103. Davey C., Wiles R., Ashbury A., and Murphy C. Falling in Parkinson's disease: the impact on informal caregivers. Disabil Rehabil 26 (2004) 1360-1366
104. Pathak A., and Senard J.M. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management. Expert Rev Cardiovasc Ther 2 (2004) 393-403